Haploidentical Stem Cell Transplantation in Neuroblastoma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Clinical Trials Related to Fludarabine
Related studies linked through entity extraction aliases.
FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies
- Status
- COMPLETED
- Phase
- NA
Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease
- Status
- COMPLETED
- Phase
- PHASE2
Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Total Marrow Irradiation for Refractory Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc)
- Status
- TERMINATED
- Phase
- PHASE1
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma
- Status
- TERMINATED
- Phase
- PHASE1
Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders
- Status
- COMPLETED
- Phase
- PHASE2
EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Hematopoietic Stem Cell Transplantation for Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using Total Body Irradiation, Cyclophosphamide and Fludarabine
- Status
- COMPLETED
- Phase
- NA
In-Vivo Activated T-Cell Depletion to Prevent GVHD
- Status
- TERMINATED
- Phase
- NA